NCT03407859View on ClinicalTrials.gov

Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 18, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Therapy Related Leukemia
Interventions
BIOLOGICAL

Sequential Treatment With different CART

Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment in Relapsed/Refractory B-ALL

Trial Locations (1)

510000

RECRUITING

Southern Medical University Zhujiang Hospital, Guangdong

All Listed Sponsors
collaborator

Nanfang Hospital, Southern Medical University

OTHER

lead

Zhujiang Hospital

OTHER